Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-07-28
1996-02-20
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 99, A61K 31485, C07D40108
Patent
active
054929148
ABSTRACT:
This invention relates to 2-(1'-azabicyclo[2.2.2]oct-3'S-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[de ]isoquinolin-1-one and 2-(1'-azabicyclo[2.2.2]oct-3'S-yl)-6-hydroxy-2,3,3a,4,5,6-hexahydro-1H-ben z[de]isoquinolin-1-one and their individual stereoisomers and uses and the processes for their making.
REFERENCES:
patent: 5202333 (1993-04-01), Berger
Clark RD. et al. J. Med. Chem. (1993) 36, 2645-2657.
Berger Jacob
Clark Robin D.
Weller Paul E.
Wren Douglas L.
Huang Evelyn
Ivy C. Warren
Montgomery Wayne W.
Syntex (U.S.A.) Inc.
LandOfFree
2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1356029